278 related articles for article (PubMed ID: 32545386)
1. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters.
Li J; Zhu HJ
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545386
[TBL] [Abstract][Full Text] [Related]
2. Ultrasensitive Quantification of Drug-metabolizing Enzymes and Transporters in Small Sample Volume by Microflow LC-MS/MS.
Ahire DS; Basit A; Karasu M; Prasad B
J Pharm Sci; 2021 Jul; 110(7):2833-2840. PubMed ID: 33785352
[TBL] [Abstract][Full Text] [Related]
3. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States.
Sharma S; Suresh Ahire D; Prasad B
J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S17-S35. PubMed ID: 33205430
[TBL] [Abstract][Full Text] [Related]
4.
Singh DK; Ahire D; Davydov DR; Prasad B
Drug Metab Dispos; 2024 Apr; ():. PubMed ID: 38641346
[TBL] [Abstract][Full Text] [Related]
5. Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics.
Bhatt DK; Prasad B
Clin Pharmacol Ther; 2018 Apr; 103(4):619-630. PubMed ID: 28833066
[TBL] [Abstract][Full Text] [Related]
6. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.
Al Feteisi H; Achour B; Rostami-Hodjegan A; Barber J
Expert Opin Drug Metab Toxicol; 2015; 11(9):1357-69. PubMed ID: 26108733
[TBL] [Abstract][Full Text] [Related]
7. Sex and the Kidney Drug-Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?
Thakur A; Yue G; Ahire D; Mettu VS; Al Maghribi A; Ford K; Peixoto L; Leeder JS; Prasad B
Clin Pharmacol Ther; 2024 Jul; 116(1):235-246. PubMed ID: 38711199
[TBL] [Abstract][Full Text] [Related]
8. Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique.
Goelen J; Farrell G; McGeehan J; Titman CM; J W Rattray N; Johnson TN; Horniblow RD; Batchelor HK
Eur J Pharm Biopharm; 2023 Oct; 191():68-77. PubMed ID: 37625656
[TBL] [Abstract][Full Text] [Related]
9. Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.
Khatri R; Fallon JK; Rementer RJB; Kulick NT; Lee CR; Smith PC
J Pharmacol Toxicol Methods; 2019; 98():106590. PubMed ID: 31158457
[TBL] [Abstract][Full Text] [Related]
10. A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation.
Ladumor MK; Thakur A; Sharma S; Rachapally A; Mishra S; Bobe P; Rao VK; Pammi P; Kangne H; Levi D; Balhara A; Ghandikota S; Joshi A; Nautiyal V; Prasad B; Singh S
Sci Rep; 2019 Jul; 9(1):9709. PubMed ID: 31273226
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat Liver and Intestinal Segments for Applications in PBPK Modeling.
Sharma S; Singh DK; Mettu VS; Yue G; Ahire D; Basit A; Heyward S; Prasad B
Mol Pharm; 2023 Mar; 20(3):1737-1749. PubMed ID: 36791335
[TBL] [Abstract][Full Text] [Related]
12. Gene expression variability in human hepatic drug metabolizing enzymes and transporters.
Yang L; Price ET; Chang CW; Li Y; Huang Y; Guo LW; Guo Y; Kaput J; Shi L; Ning B
PLoS One; 2013; 8(4):e60368. PubMed ID: 23637747
[TBL] [Abstract][Full Text] [Related]
13. Application of proteomics to understand maturation of drug metabolizing enzymes and transporters for the optimization of pediatric drug therapy.
Streekstra EJ; Russel FGM; van de Steeg E; de Wildt SN
Drug Discov Today Technol; 2021 Dec; 39():31-48. PubMed ID: 34906324
[TBL] [Abstract][Full Text] [Related]
14. The Promises of Quantitative Proteomics in Precision Medicine.
Prasad B; Vrana M; Mehrotra A; Johnson K; Bhatt DK
J Pharm Sci; 2017 Mar; 106(3):738-744. PubMed ID: 27939376
[TBL] [Abstract][Full Text] [Related]
15. Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics.
Prasad B; Unadkat JD
AAPS J; 2014 Jul; 16(4):634-48. PubMed ID: 24752720
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.
Ahire D; Kruger L; Sharma S; Mettu VS; Basit A; Prasad B
Pharmacol Rev; 2022 Jul; 74(3):769-796. PubMed ID: 35738681
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in the quantification of drug metabolizing enzymes and transporters by proteomic approach].
Yang B; Wang J; Cong YT; Hu LH; Gu JK
Yao Xue Xue Bao; 2015 Jun; 50(6):668-74. PubMed ID: 26521435
[TBL] [Abstract][Full Text] [Related]
18. Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations.
Chothe PP; Arya V; Prasad B; Ramsden D; Taskar K
Drug Metab Dispos; 2023 Dec; 51(12):1547-1550. PubMed ID: 37775331
[TBL] [Abstract][Full Text] [Related]
19. An improved liquid chromatography tandem mass spectrometry (LC-MS/MS) method for quantification of dexmedetomidine concentrations in samples of human plasma.
Moosavi SM; Shekar K; Fraser JF; Smith MT; Ghassabian S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():118-122. PubMed ID: 29248769
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometry of Human Transporters.
Achour B; Al-Majdoub ZM; Rostami-Hodjegan A; Barber J
Annu Rev Anal Chem (Palo Alto Calif); 2020 Jun; 13(1):223-247. PubMed ID: 32084322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
